Literature DB >> 11071473

Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables.

M Jagoditsch1, P H Lisborg, G R Jatzko, V Wette, G Kropfitsch, H Denk, M Klimpfinger, H M Stettner.   

Abstract

Despite the improvement in its prognosis in most Western countries, death from colon cancer is still a major problem. In a prospectively planned observation study, a large patient collective from a single institution in Austria was analyzed in terms of the surgical approach and factors influencing survival. A total of 696 patients with colonic carcinomas were admitted to our surgical department between January 1, 1984 and December 31, 1997. Radical surgery for localized tumors was consistently performed, including wide resection margins and complete removal of the regional lymph drainage zones. Clinical, histopathologic, and therapy-related factors were examined for their influence on long-term survival by means of univariate and multivariate analysis. The overall tumor resection rate was 99.3% (691/696); complete tumor removal (R0) was possible for 84.8% (590/696) of all patients. The overall postoperative hospital mortality rate was 3.2% (22/696), and it was 13% (7/556) for potentially curative resections. Five- and ten-year tumor-specific survival rates for stage I to III R0 resections were 83.8% and 78.8%, respectively. Adjuvant chemotherapy reduced tumor recurrence for stage III patients by 52.4%. The depth of tumor infiltration, lymph node status, and adjuvant chemotherapy were found to have an independent influence on survival as identified by the Cox models. In conclusion, a consistent radical surgical approach for potentially curative resected colonic cancer patients had survival rates that surpassed those of most published series without sacrificing low complication rates. In addition, adjuvant chemotherapy for stage III substantially improved survival.

Entities:  

Mesh:

Year:  2000        PMID: 11071473     DOI: 10.1007/s002680010252

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  The effect of the surgeon and the pathologist on patient survival after resection of colon and rectal cancer.

Authors:  James W Fleshman
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

2.  Revisiting the prognostic relevance of muscle mass among non-metastatic colorectal cancer.

Authors:  Omar Abdel-Rahman; Winson Y Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-13

3.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods.

Authors:  Avraham Belizon; Emre Balik; Daniel L Feingold; Marc Bessler; Tracey D Arnell; Kenneth A Forde; Patrick K Horst; Suvinit Jain; Vesna Cekic; Irena Kirman; Richard L Whelan
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

5.  Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer.

Authors:  H M C Shantha Kumara; Elli Sutton; Geoffrey A Bellini; Xiaohong Yan; Vesna Cekic; Nipa Dilip Gandhi; Richard L Whelan
Journal:  Mol Clin Oncol       Date:  2017-12-18

6.  Laparoscopic complete mesocolic excision for right colon cancer.

Authors:  Michel Adamina; Mark L Manwaring; Ki-Jae Park; Conor P Delaney
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

7.  Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection.

Authors:  H M C Shantha Kumara; Elizabeth A Myers; Sonali Ac Herath; Joon Ho Jang; Linda Njoh; Xiaohong Yan; Daniel Kirchoff; Vesna Cekic; Martin Luchtefeld; Richard L Whelan
Journal:  World J Gastrointest Oncol       Date:  2014-10-15

8.  Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy.

Authors:  Marco Tampellini; Maria Pia Brizzi; Raffaella Bitossi; Irene Alabiso; Carla Maria Sculli; Luigi Chiusa; Mauro Papotti; Luigi Dogliotti
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-06       Impact factor: 4.553

9.  Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model.

Authors:  Frédéric Borie; Christophe Combescure; Jean-Pierre Daurès; Brigitte Trétarre; Bertrand Millat
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

10.  Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; George A Luiken; Mark A Talamini; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2013-11-19       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.